Divalent cobalt as a label to study lymphocyte distribution using PET and SPECT

Journal of Nuclear Medicine

Volumn 39, Issue 5, 1998, Pages 836-841

  Korf, Jakob ^a   Veenma Van Der Duin, Lammy ^b   Brinkman Medema, Rikje ^b   Niemarkt, Anita ^b   De Leij, Lou F M H ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Calcium; Cobalt; Lymphocytes; PET; SPECT

Indexed keywords

CALCIMYCIN; CALCIUM ION; COBALT; COBALT 55; COBALT 57; COBALT CHLORIDE; DIVALENT CATION; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LABELING; CONTROLLED STUDY; CYTOTOXICITY; DRUG HALF LIFE; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LYMPHOCYTE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIOACTIVITY; RADIOISOTOPE DISTRIBUTION; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CALCIUM CHLORIDE; COBALT; COBALT RADIOISOTOPES; FEMALE; HALF-LIFE; HUMANS; ISOTOPE LABELING; LYMPHOCYTES; MALE; RATS; RATS, WISTAR; TIME FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 2642659394     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Gajewski TF, Schell SR, Nau G, Fitch FW. Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev 1989;111:79-109.
2. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-66.
3. Lichtman AH, Abbas AK. T-cells subsets: recruiting the right kind of help. Curr Biol 1997;7:R242-244.
4. Mukherji B, Arnbjarnarson O, Spitznagle LA, et al. Imaging pattern of previously in vitro sensitized and interleukin-2 expanded autologous lymphocytes in human cancer. Nucl Med Biol 1988;15:419-427.
5. Kuyama J, McCormick A, George AJT, et al. Indium-111 labelled lymphocytes isotope distribution and cell division. Eur J Nucl Med 1997;24:488-496.
6. Botti C, Negri DRM, Seregni E, et al. Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur J Nucl Med 1997;24:497-504.
7. Thakur ML, Marcus C, Huynh TV, et al. Imaging rheumatoic joint disease with anti-T-lymphocytes antibody OKT-3. Nucl Med Commun 1994;15:824-830.
8. Heinel LA, Rubin S, Rosenwasser RH, Vasthare US, Tuma RF. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Brain Res Bull 1994;34:137-141.
9. Holda JH, Swanborg RH. Autoimmune effector cells: II. Transfer of experimental allergic encephalomyelitis with a subset of T-lymphocytes. Eur J Immunol 1982;12: 453-455.
10. Jander S, Kraemer M, Schroeter M, Witte OW, Stoll G. Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab 1995;15:42-51.
11. 2+ influx in T lymphocytes from patients with multiple sclerosis. Proc Natl Acad Sci USA 1994;91:4825-4829.
12. 2+ influx in patients with relapsing-remitting multiple sclerosis. Neurology 1996;46:1416-1421.
13. Bekerman C, Nayak SM. Gallium imaging. In: Henkin RE, Boles MA, Karesh SM, et al., eds. Nuclear medicine. St. Louis, MO: Mosby YearBook; 1996:1597-1618.
14. Callahan RJ, Ramberg KL. Radiolabeling formed elements of blood: methods and mechanisms. In: Henkin RE, Boles MA, Karesh SM, et al., eds. Nuclear medicine. St. Louis, MO: Mosby YearBook; 1996:397-409.
15. Coleman RE, Datz FL. Detection of inflammatory disease using radiolabeled cells. In: Sandler MP, Patton JA, Coleman RE, Gottschalk A, Wackers FJTh, Hofferm PB, eds. Diagnostic nuclear medicine, 3rd ed. Baltimore: Williams and Wilkins; 1996:1509-1524.
16. Forstom L. Indium-111 labeled leukocyte imaging in the diagnosis of infaction and inflammatory disease. In: Henkin RE, Boles MA, Karesh SM, et al., eds. Nuclear medicine. St. Louis, MO: Mosby Yearbook; 1996:1619-1635.
17. Neumann RD, McAfee JG. Gallium-76 imaging in infection. In: Sandler MP, Patton JA, Coleman RE, Gottschalk A, Wackers FJTh, Hofferm PB, eds. Diagnostic nuclear medicine, 3rd ed. Baltimore: Williams and Wilkins; 1996;1493-1507.
18. 99mTc HMPAO labeled leukocytes. In: Henkin RE, Boles MA, Karesh SM, et al., eds. Nuclear medicine. St. Louis, MO: Mosby Yearbook; 1996:1636-1655.
19. Melder RJ, Elmaleh D, Brownell AL, Brownell GL, Jain RK. A method for labeling cells for positron emission tomography (PET) studies. J Immunol Meth 1994;175:79-87.
20. 55Co positron emission tomography. J Nucl Med 1994;35: 456-460.
21. 55Co positron emission tomography in man. J Cereb Blood Flow Metab 1993; 13(suppl):S707-S708.
22. Jansen HML, Paans AMJ, Van der Vliet AM, et al. Cobalt-55 positron emission tomography in ischemic stroke. Clin Neurol Neurosurg 1997;99:6-10.
23. Jansen HML, Van der Naalt J, Van Zomeren AH, et al. Cobalt-55 positron emission tomography in traumatic brain injury: a pilot study. J Neural Neurosurg Psychol 1996;60:221-223.
24. Jansen HML, Willemsen ATM, Sinnige LGF, et al. Cobalt-55 positron emission tomography in relapsing-progressive multiple sclerosis. J Neural Sci 1995;132:139-145.
25. Joosten AAJ, Jansen HML, Piers A, Minderhoud JM, Korf J. Cobalt-57 SPECT in relapsing-progressive multiple sclerosis: a pilot study. Nucl Med Commun 1995;16: 703-705.
26. Stevens H, Jansen HML, DeReuck J, Korf J. imaging of stroke. In: Ter Horst GJ, Korf J, eds. Clinical pharmacology of cerebral ischemia. Totowa, NJ: Humana Press; 1997:31-42.
27. 2 positron emission tomography. J Neurochem 1988;50:1798-1807.
28. Jansen HML, Knollema S, Veenma-van der Duin L, et al. Pharmacokinetics and dosimetry of 55- and 57-cobalt chloride. J Nucl Med 1996;37:2082-2087.
29. Pressman BC. Biological applications of ionophores. Ann Rec Biochem 1976;45:501-532.
30. Osman S, Danpure HJ. Fluorine-18-2-fluorodeoxy-D-glucose (18-FDG) labelling of human granulocytes to study inflammation by positron emission tomography (PET) [Abstract]. Eur J Nucl Med 1989;15:577.
31. Weiss A, Wiskocil RL, Stobo JD. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for I1-2 production reflects events occurring at a pre-translational level. J Immunol 1984;133:123-128.
32. Polman CH, Matthaei I, de Groot CJA, Koetsier JC, Sminia T, Dijkstra C. Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat. J Neuroimmunol 1988;17:209-216.
33. Wang P-Y, Kao C-H, Mui M-Y, Wang S-J. Leukocyte infiltration in acute hemispheric ischemic stroke. Stroke 1993;24:236-240.
34. Wekerle H. Lymphocyte traffic to the brain. In: Pardridge WA, ed. Blood brain barrier. New York: Raven Press; 1993;67-81.